BRIEF-Capricor Therapeutics Granted Orphan Drug And ATMP Status For Deramiocel By European Medicines Agency

Reuters
20 Nov 2024
BRIEF-Capricor <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Granted Orphan Drug And ATMP Status For Deramiocel By European Medicines Agency

Nov 20 (Reuters) - Capricor Therapeutics Inc CAPR.O:

  • CAPRICOR THERAPEUTICS GRANTED ORPHAN DRUG AND ATMP STATUS FOR DERAMIOCEL BY EUROPEAN MEDICINES AGENCY

  • CAPRICOR THERAPEUTICS INC - EXPECTS TO COMPLETE BLA SUBMISSION BY END OF 2024

Source text: ID:nGNX12TY7n

Further company coverage: CAPR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10